To evaluate the relevance of calcifi cations for invasive breast cancer detection in population-based digital mammographic screening.
This study was approved by an independent ethics committee, and no additional informed consent was required. Prospectively documented radiologic cancer features were correlated with pathologic characteristics in 241 breast malignancies diagnosed in 24 067 participating women aged 50-69 years (part of the digital German Screening Program; initial screening rate, 92%; detection rate [DR], 1.0%; recall rate [RR], 7.5%). The rates of invasive cancers detected on the basis of calcifi cations were analyzed against pathologic tumor categories (pT categories) and histologic grades. For comparison of the study data with results of analog screening, data from the literature regarding calcifi cation-specifi c RR, DR, and positive predictive value for recall (PPV 1 ) were calculated.
Results:
The calcifi cation-specifi c RR was 1.7% (416 of 24 067). The calcifi cation-specifi c DR for invasive cancer was 0.12% (29 of 24 067), and the PPV 1 was 7.0% (29 of 416). Of all malignancies detected on the basis of calcifi cation, 38% (29 of 77) were invasive. pT1 cancers showed an inverse association between tumor size and rate of detection on the basis of calcifi cation; differences in rates among pT1 subcategories were statistically signifi cant ( P , .001). The proportion of grade 1 pT1 cancers detected on the basis of calcifi cation (eight of 27) did not differ signifi cantly from that of cancers detected on the basis of other radiologic features (46 of 108, P = .24). The calcifi cation-specifi c invasive cancer DR was signifi cantly higher for digital than for analog mammography. breast screening often conclude that the high rates of calcifi cations detected represent overdiagnosis, with many calcifications representing instances of DCIS that would never manifest clinically. In contrast to that idea and irrespective of the existence of evidence for a direct contribution of DCIS detection to the benefi ts of screening (11) (12) (13) , there is a strong correlation between rates of detection of DCIS and rates of detection of small invasive cancers at screen-fi lm mammography ( 14 ) . The objective of our study was to estimate the relevance of calcifi cations for invasive cancer detection in population-based digital mammographic screening.
Materials and Methods
Our study correlates prospectively documented radiologic data of cancer morphology with the pathologic characteristics of 241 breast malignancies detected at one digital screening unit of the German nationwide program in 241 women who underwent mammographic screening from October 1, 2005, to August 31, 2008 , and fi nal surgical therapy by May 31, 2009 .
The implementation of the population-based mammographic screening program started in October 2005. The program adheres to the European guidelines ( 15, 16 ) . Accordingly, the target population includes all women between the ages of 50 and 69 years who are invited within the specifi ed screening interval of 2 years. Before a participant undergoes mammography, she has to give written informed consent to have her personal data handled according to the national program rules ( 16, 17 ) . These rules allow the use of personal data for the internal quality assurance of the screening unit. For this scientifi c study, the data were used T he introduction of digital mammographic techniques into screening practice has been slow, despite the considerable advantages of digital mammography over conventional screen-fi lm mammography ( 1, 2 ) . The most important question addressed so far is whether the accuracy of digital mammography in population-based screening is equivalent to that of analog mammography. Results of large prospective trials ( 1, (3) (4) (5) (6) (7) (8) (9) (10) have indicated that digital mammography is at least as accurate as screen-fi lm mammography in current screening practice.
In contrast to the traditional belief that calcifi cations are best detected at screen-fi lm mammography because of its higher spatial resolution, Del Turco et al ( 10 ) found in digital screening practice a high detection rate for cancers depicted as calcifi cations, most of which represented ductal carcinoma in situ (DCIS). This corresponds to the generally higher DCIS rates reported for digital screening than for screenfi lm screening ( 1, 9, 10 ) . Critics of digital
Implication for Patient Care
Implementation of digital mamn mography increases the calcifi cation-specifi c invasive cancer detection rate in populationbased screening.
Advances in Knowledge
Invasive tumors detected on the n basis of calcifi cations in population-based digital mammographic screening tend to be smaller (median, 7 mm) than those detected on the basis of masses (median, 14 mm; P , .001), architectural distortions (median, 15 mm; P = .003), or combinations of features (median, 17 mm; P , .001).
Invasive tumors detected on the n basis of calcifi cations in population-based digital mammographic screening do not show an increased rate of histologic grade 1 disease and consequently seem to be of at least no lower intrinsic aggressiveness than those generally detected with screening.
The calcifi cation-specifi c detecn tion rate for invasive cancers in population-based screening is higher for digital than for analog mammography. The distribution of the pathologic tumor (pT) categories is shown in Table 1 . To avoid hampering of the downstream analysis by the extremely low number of pTmic cancers, they were combined with the pT1a cancers into one group (pT1a/pTmic) for further analysis. This combination was also justifi ed by a lack of evidence of different prognoses for these subcategories in patients with negative lymph nodes.
Finally, so that we could compare our results with those from screen-fi lm mammographic screening, we used data published by Del Turco et al ( 10 ) . They examined the diagnostic accuracy of digital and screen-fi lm mammography within a population-based screening program that adhered to the European guidelines in a setting similar to that of our study. We rendered their detailed data and calculated the recall rate, detection rate, and PPV 1 of calcifi cations regarding invasive cancer separately for the digital and analog cohorts of their series.
Statistical Analysis
For the fi nding of isolated calcifi cations, recall rate, detection rate, and PPV 1 were was presented at a consensus meeting. Both of the primary readers and one additional third reader decided at the consensus meeting whether patient recall for further assessment was recommended. The recalled cases were fi nally classifi ed during the consensus meeting as BI-RADS category 4a, 4b, or 5. Each lesion was described according to the following terminology: (a) calcifi cations only, (b) calcifi cations in combination with a mass lesion, (c) calcifi cations in combination with an architectural distortion, (d) mass only, and (e) architectural distortion only. Both the fi nal BI-RADS category and the morphology assigned at the consensus meeting were directly recorded into a central database. Once documented in the fi le, the data were no longer alterable and were used for the present study. No cancer was detected at clinical presentation only.
Study Design and Patients
The centrally prospectively documented data from the consensus meetings as part of the routine screening process were used for the analysis of BI-RADS category ( 19 ) and cancer morphology in digital screening mammography. There was no further review of images for this study. Results of further assessment procedures after the primary mammographic examination were not taken into account for this study.
The included breast cancers comprised 97.2% (241 of 248) of all malignancies detected in 24 067 participants screened during the same period. The remaining seven patients were not included because surgery was not performed by May 2009. Of the 241 included screening-detected malignancies, 22 (9.1%) were diagnosed in the subsequent round of screening. Because of this small proportion of second round-detected cancers resulting from the small number of women undergoing a subsequent screening examination in our cohort (8% [1925 of 24 067]), we decided not to analyze the data from both screening rounds separately.
Pathologic investigation of all surgical specimens was performed according to the European guidelines ( 20 ) . All three pathologists (T.D., D.H., and
Equipment and Routine Screening Process
The screening unit obtained all screening mammograms by using exclusively digital techniques. One full-fi eld scanning system (MicroDosis Mammography, MDM/L30; Sectra Medical Systems, Linköping, Sweden) (pixel size, 50 µm) and one computed radiography system (Mammomat 3000 Nova, Siemens, Erlangen, Germany; with DirectView CR 975 EHR-M2, Carestream Health, Rochester, NY) (pixel size, 50 µm) were used. All devices fulfi lled national requirements ( 18 ) , as well as the requirements for contrast resolution of the European Protocol for the Quality Control of the Physical and Technical Aspects of Mammography Screening Addendum on Digital Mammography ( 15 ) . Two-view mammograms were obtained at each screening examination.
The screening unit had been certifi ed according to the regulations of the screening program, which included dedicated training and qualifi cation of radiographers and radiologists ( 15, 16 ) . Readings were performed by two of fi ve specialized radiologists (eg, S.W., W.H.), each of whom had at least 4 years of experience in breast imaging prior to the start of screening. Each interpreted a volume of 3000 mammograms in the 1st year of the program, followed by 5000-6000 mammograms in each subsequent year.
In the screening setting, soft-copy double reading was performed independently by using a monochrome liquid crystal display panel (ME 511; Totoku Elec tric, Tokyo, Japan) with a resolution of 2560 3 2048 pixels and high luminance and contrast (maximum luminance, 750 candelas per square meter; contrast: 800:1); the hanging protocol included full resolution with a 1:1 pixel ratio.
No computer-assisted detection system was used. Results of prior screening examinations were provided for reading; no magnifi cation views existed.
If ( Table 3 ) . the remaining two were pT2 tumors. Calcifi cation-specifi c tumor detection rates differed signifi cantly between the individual pT1 subgroups, being highest in the pT1a/pTmic subgroup at 55% and decreasing to 5% in the pT1c subgroup ( P , .001, Table 2 Figure ) . Compared with the calcifi cationspecifi c invasive cancer detection rate of 0.04% (overall detection rate, 0.58%) in the analog screening cohort of Del Turco et al ( 10 ) , the respective rates were signifi cantly higher in both the digital screening cohort of Del Turco et al (0.11%; P = .032; overall detection rate, 0.72%) and in our study group (0.12%; P = .013; overall detection rate, 1.0%). Although the PPV 1 (30%) of isolated calcifi cations in all malignancies in the analog cohort was signifi cantly higher than the PPV 1 in both digital studies-the digital cohort of Del Turco et al (25%, P , .001) and our study group (19%, P , .001)-the respective difference for invasive cancers detected on the basis of calcifi cations was smaller ( Table 5 ) .
Discussion
More than 20 years ago, Sickles ( 25 ) demonstrated that calcifi cations are relevant for the detection of invasive cancers, which was further confi rmed by more recent studies of screen-fi lm fi ed as BI-RADS category 5, six were DICS and one was invasive cancer. Moreover, 48% (14 of 29) of all invasive cancers detected on the basis of calci-A majority (70 of 77) of malignancies detected on the basis of calcifi cations were labeled as BI-RADS category 4. Of the seven remaining cases classi- Note.-Data are numbers of malignancies, with percentages based on the total of 77 malignancies in parentheses. Categories were defi ned at screening mammography during the consensus meeting. The sensitivity indicators in our study are in keeping with the European standards for screening and with recent reports ( 9, 30 ) . Therefore, we assume that our study population is representative of patients with cancers detected at population-based digital mammographic screening.
To our knowledge, there are no previous reports about the tumor sizes and grades of invasive cancers diagnosed after recall of patients with calcifi cations in population-based digital screening. We detected an inverse relationship between invasive tumor size and the rate of cancers detected on the basis of calcifi cations. The smaller the tumors, the more likely they were to be detected on the basis of calcifi cations alone (Figure) . Within the group of small invasive cancers that were 10 mm or smaller (pT1b, pT1a/pTmic), the rate of tumors detected on the basis of calcifi cations was 35%, representing 83% of all invasive cancers detected on the basis of this feature.
Histologic grade according to the Nottingham system is generally accepted as a strong prognostic factor, even for tumors 10 mm or smaller ( 31 ) . Moreover, data suggest that grade 1 cancers less than 20 mm in size (pT1) and grade 2 and 3 cancers less than 10 mm in size detected at screening show a lower likelihood of developing metastases ( 32 ) . Therefore, to answer the question of whether invasive pT1 cancers detected on the basis of calcifi cations tend to be of higher or lower malignant potential, we analyzed their histologic grade distribution. According to the grade distribution of carcinomas detected on the basis of calcifi cations, grade 1 cancers were at least not overrepresented, and we interpret this result as an indication of a similar rate of aggressive cancers in this group. This suggests that detection of invasive tumors on the basis of calcifi cations alone does not mean detection of predominantly less aggressive cancers but rather contributes to the In our study, in accordance with other studies of population-based digital mammography programs ( 1, 9, 10 ) , most malignancies detected on the basis of calcifi cations were DCIS; however, 38% proved to be invasive cancers. A similar proportion was reported by Stomper et al ( 29 ) ; they found that of all breast malignancies detected on the basis of calcifi cations on mammograms, 36% were invasive cancers. However, their results are not necessarily comparable to ours, which come from a population-based program with a different target population. On the basis of the detailed data presented by Del Turco et al ( 10 ), we calculated that even in their digital study cohort, about 42% of malignancies detected on the basis mammography (26) (27) (28) (29) . However, to our knowledge, the studies on digital mammography have not specifi cally analyzed the rate of invasive cancers detected on the basis of calcifi cations as the sole fi nding ( 1,3,4,8-10,30 ). To date, because of widespread national implementation of digital mammography in practice, it is not feasible to generate data comparing digital and screen-fi lm techniques in prospective randomized studies.
Looking at detailed data, the percentages of malignancies detected on the basis of calcifi cations at digital screening reported by Skaane and Skjennald ( 6 ) and Del Turco et al ( 10 ) were, at 32% and 37%, respectively, similar to our rate of 32%. ( 36, 37 ) . Our fi rstround recall rate is slightly higher than the acceptable target given in the European guidelines, lower that recommended in the United States, and in agreement with the evidence-based results of Schell et al ( 38 ) . Our relatively high recall rate of 7.5% was not due to the calcifi cationspecifi c recall rate (1.7%), while the calcifi cation-specifi c PPV 1 (19%) was higher than the overall PPV 1 of 14%.
Our study had further limitations. First, we used the 3rd edition of the BI-RADS manual and therefore did not have a category 4c ( 39 ) . Thus, our results cannot be directly compared with those obtained by using current BI-RADS descriptors. Second, we combined our prevalent and incident screens, and our data are thus not directly comparable to either prevalent or incident screens. Third, our data are from a single screening program with double reading, with techniques that may not necessarily be applicable to other programs that use a different protocol. Fourth, we did not assess breast density, which could have obscured masses associated with calcifi cations. screening benefi t. To verify this, studies with larger sample sizes and longer follow-up are needed. This result is in line with the study of Del Turco et al ( 10 ) , but the value of that study concerning grade is limited, because fi ve of 16 invasive tumors detected on the basis of calcifi cations could not be included.
Analyzing the distribution of the BI-RADS categories, BI-RADS 4 was the dominant category for malignancies detected on the basis of calcifi cations for DCIS and invasive cancer. About half of these invasive cancers were categorized as BI-RADS 4a.
In European trials, there is evidence of a signifi cantly higher detection rate for malignancies detected on the basis of calcifi cations in digital versus analog screening against the background of signifi cantly higher recall and overall cancer detection rates ( 5,9,10,33 ). In accordance with this, when we compared the digital and analog techniques, we found in both digital studies-the digital cohort of Del Turco et al ( 10 ) and our digital study group-higher calcifi cationspecifi c recall rates (1.1% and 1.7%, respectively) associated with higher calcifi cation-specifi c detection rates (0.26% and 0.32%, respectively) than in the analog screen-fi lm cohort in the study of Del Turco et al (calcifi cationspecifi c recall rate, 0.4%; calcifi cationspecifi c detection rate, 0.12%). Analyzing the calcifi cation-specifi c detection rate for invasive cancers, we found a similar trend (the calcifi cation-specifi c detection rate for invasive cancers was 0.11% for the digital cohort in the Del Turco et al study and 0.12% in our study, vs 0.04% for the analog cohort in the former study). Consequently, our observations suggest that digital screening may increase the detection rate of invasive carcinomas-in our study, predominantly those 2 cm or smaller.
Accordingly, in the Dutch study by Karssemeijer et al ( 34) , the comparison of full-fi eld digital mammography (FFDM) performed with computeraided diagnosis (CAD) and screen-fi lm mammography resulted in a fi nding of improved detection of microcalcifi cations with FFDM. The fraction of invasive cancers with microcalcifi ca-
